Enforcement record
Business Suspension Order disclosure naming 一般財団法人化学及血清療法研究所
This page records one action from a Japanese government disclosure, including the published name, governing law, authority, action details, and official source.
Action type
Business Suspension Order
Law
医薬品医療機器法
Authority
Ministry of Health, Labour and Welfare
Action date
18 January 2016
Current page: Enforcement record
This screen focuses on one disclosed action: the published name, governing law, authority, facts, source status, and review evidence.
Source verification
Public-source and preservation status
- Publishing authority
- Ministry of Health, Labour and Welfare
- Official source URL
- Recorded by RegBase
- Entity match
- Not confirmed; shown under the published name
- Kiroku preservation
- Queued for preservation
- Captured: Jul 12, 2026, 03:24 PM JST
“Confirmed” means that RegBase matched this record to the cited public disclosure or entity under the stated checks. It does not verify the truth of the disclosure or guarantee the entity’s current status, creditworthiness, or any legal conclusion.
Available sources and saved files are listed in the public documents section below.
Public documents and saved materials
View the original publications, see what was preserved, or download each file below.
Loading materials…
Action summary
- Company
- 一般財団法人化学及血清療法研究所Japanese onlyOriginal: 一般財団法人化学及血清療法研究所
- Governing law
- 医薬品医療機器法医薬品医療機器法
- Action type
- Business Suspension Order業務停止命令
- Action date
- 18 January 2016
- Issuing authority
- Ministry of Health, Labour and Welfare厚生労働省
- Industry context
- 医薬品医療機器
Violation
The Ministry of Health, Labour and Welfare has issued an administrative suspension order to the General Incorporated Foundation, Chemical and Serum Therapy Institute, based on Article 75, Paragraph 1 of the Pharmaceuticals and Medical Devices Act, for a period of 110 days from January 18, 2016 (Monday) to May 6, 2016 (Friday).
Show original Japanese text
厚生労働省では、本日付けで、一般財団法人化学及血清療法研究所に対し医薬品医療機器法第75条第１項の規定に基づき、別紙のとおり平成28年１月18日(月)から同年５月６日(金)までの110日間の業務停止命令(行政処分)を行いましたので、お知らせします。
Compliance context
HighA formal order requiring suspension of business activities for the covered scope or period.
Japanese regulatory disclosure under 医薬品医療機器法.
Escalate for legal or third-party risk review before onboarding or continuing a material relationship.
This context is an operational aid for review workflows, not a credit opinion or legal conclusion.
Language
日本語版を見る (Japanese)About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.